196 related articles for article (PubMed ID: 38664705)
1. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication.
Chen D; Liu P; Lu X; Li J; Qi D; Zang L; Lin J; Liu Y; Zhai S; Fu D; Weng Y; Li H; Shen B
J Exp Clin Cancer Res; 2024 Apr; 43(1):125. PubMed ID: 38664705
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.
Zhang Z; Wang ZX; Chen YX; Wu HX; Yin L; Zhao Q; Luo HY; Zeng ZL; Qiu MZ; Xu RH
Genome Med; 2022 Apr; 14(1):45. PubMed ID: 35488273
[TBL] [Abstract][Full Text] [Related]
3. A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence.
Wu Z; Uhl B; Gires O; Reichel CA
J Biomed Sci; 2023 Mar; 30(1):21. PubMed ID: 36978029
[TBL] [Abstract][Full Text] [Related]
4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
5. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques.
He D; Tang H; Yang X; Liu X; Zhang Y; Shi J
Front Immunol; 2023; 14():1278496. PubMed ID: 37965333
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy.
Feng JL; Liang B; Zheng WJ; Xu L; Zhou QY; Chen J
Cancer Immunol Immunother; 2024 May; 73(7):121. PubMed ID: 38714579
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
9. Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring.
Gao Y; Chen S; Wang H; Wu C; An R; Li G; Yang M; Zhou Y; Zhou Y; Xie X; Yu H; Zhang J
J Adv Res; 2023 Aug; ():. PubMed ID: 37619932
[TBL] [Abstract][Full Text] [Related]
10. The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinoma.
Zhang P; Pei S; Gong Z; Ren Q; Xie J; Liu H; Wang W
Front Endocrinol (Lausanne); 2023; 14():1154410. PubMed ID: 37033259
[TBL] [Abstract][Full Text] [Related]
11. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C
Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
13. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
Chai R; Zhao Y; Su Z; Liang W
Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
Front Immunol; 2021; 12():758288. PubMed ID: 34804045
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response.
Zhang W; Zhu Y; Liu H; Zhang Y; Liu H; Adegboro AA; Dang R; Dai L; Wanggou S; Li X
NPJ Precis Oncol; 2024 Mar; 8(1):77. PubMed ID: 38538696
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.
Liu C; Xie J; Lin B; Tian W; Wu Y; Xin S; Hong L; Li X; Liu L; Jin Y; Tang H; Deng X; Zou Y; Zheng S; Fang W; Cheng J; Dai X; Bao X; Zhao P
Adv Sci (Weinh); 2024 Apr; ():e2401061. PubMed ID: 38569519
[TBL] [Abstract][Full Text] [Related]
20. T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis.
Fan Z; Liu Y; Li C; Jiang Y; Wang N; Wang M; Li C; Diao Y; Qiu W; Zhu X; Wang G; Cai S; Yang T; Lv G
iScience; 2024 Jan; 27(1):108701. PubMed ID: 38222108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]